Original Source(s)
Related Content
AI cuts lesion measurement time by 34%
Automated lesion measurements increased agreement on treatment response, although expert-generated proposals were accepted more often and required fewer adjustments.
September 3, 2026
-
4 min
FDA monthly preview: Key September decisions to watch
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
-
5 min
FDA approves serial liquid biopsy testing
In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.
September 8, 2026
-
2 min
